Brett R. Hagen's Insider Trades & SAST Disclosures
Brett R. Hagen's most recent trade in Kalaris Therapeutics Inc. was a trade of 96 Common Stock done at an average price of $10.1 . Disclosure was reported to the exchange on Feb. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brett R. Hagen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 21 Feb 2025 | 96 | 2,832 | - | 10.1 | 967 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.47 per share. | 23 Jan 2025 | 32 | 2,932 | - | 9.5 | 303 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 23 Jan 2025 | 4 | 2,928 | - | 10 | 40 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 10 Jan 2025 | 332 | 68,174 | - | 0.4 | 146 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 19 Nov 2024 | 554 | 68,506 | - | 0.5 | 304 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.86 per share. | 05 Nov 2024 | 1,655 | 69,060 | - | 0.9 | 1,431 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.77 per share. | 21 Oct 2024 | 486 | 70,715 | - | 0.8 | 373 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 21 Oct 2024 | 479 | 71,201 | - | 0.8 | 373 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 03 Oct 2024 | 301 | 71,680 | - | 0.8 | 245 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.76 per share. | 19 Aug 2024 | 544 | 71,981 | - | 0.8 | 413 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 05 Aug 2024 | 1,692 | 72,525 | - | 0.7 | 1,243 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.74 per share. | 19 Jul 2024 | 481 | 74,217 | - | 0.7 | 356 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 19 Jul 2024 | 479 | 74,698 | - | 0.7 | 359 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 02 Jul 2024 | 304 | 75,177 | - | 0.7 | 219 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 17 May 2024 | 541 | 75,481 | - | 0.7 | 405 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 03 May 2024 | 1,597 | 76,022 | - | 0.8 | 1,271 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 19 Apr 2024 | 480 | 77,619 | - | 0.8 | 360 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 19 Apr 2024 | 473 | 78,099 | - | 0.8 | 355 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.77 per share. | 02 Apr 2024 | 281 | 78,572 | - | 0.8 | 217 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Hagen Brett R. | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 20 Feb 2024 | 494 | 78,853 | - | 0.7 | 343 | Common Stock |
|
Kalaris Therapeutics Inc.
|
R. Hagen Brett | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 08 Feb 2024 | 11,150 | 79,347 | - | 0.7 | 7,494 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Hagen R. Brett | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 05 Feb 2024 | 5,792 | 90,497 | - | 0.7 | 3,881 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Hagen R. Brett | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 23 Jan 2024 | 901 | 96,289 | - | 0.7 | 604 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Hagen R. Brett | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 04 Jan 2024 | 310 | 97,190 | - | 0.6 | 198 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett Hagen R. | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.74 per share. | 27 Dec 2023 | 28,335 | 97,500 | - | 0.7 | 20,838 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 17 Aug 2023 | 1,653 | 127,175 | - | 2.5 | 4,125 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.56 per share. | 19 Jul 2023 | 342 | 129,170 | - | 3.6 | 1,218 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.35 per share. | 19 Jul 2023 | 342 | 128,828 | - | 3.3 | 1,145 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.64 per share. | 09 Jun 2023 | 5,045 | 129,512 | - | 5.6 | 28,453 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.62 per share. | 19 Apr 2023 | 349 | 134,557 | - | 3.6 | 1,265 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.71 per share. | 19 Apr 2023 | 348 | 134,906 | - | 3.7 | 1,291 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 113,750 | 251,708 | - | - | Stock Option (Right to Buy) | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 61,250 | 135,254 | - | 0 | Common Stock | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 19 Jan 2023 | 1,557 | 74,342 | - | 5.1 | 7,906 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.14 per share. | 19 Jan 2023 | 338 | 74,004 | - | 5.1 | 1,739 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.18 per share. | 10 Nov 2022 | 18,011 | 75,899 | - | 8.2 | 147,258 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 10 Nov 2022 | 5,989 | 93,910 | - | 8.0 | 47,925 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.36 per share. | 20 Oct 2022 | 345 | 113,233 | - | 9.4 | 3,229 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 20,000 | 113,578 | - | 0 | Common Stock | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 19,500 | 19,500 | - | - | Stock Option (Right to Buy) | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 10,500 | 93,578 | - | 0 | Common Stock | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.68 per share. | 20 Apr 2022 | 276 | 80,368 | - | 6.7 | 1,845 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 20 Jan 2022 | 1,563 | 63,202 | - | 8.8 | 13,680 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 42,558 | 42,558 | - | - | Stock Option (Right to Buy) | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 17,442 | 80,644 | - | 0 | Common Stock | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 43.14 per share. | 22 Feb 2021 | 800 | 64,765 | - | 43.1 | 34,509 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 40.39 per share. | 18 Feb 2021 | 541 | 65,565 | - | 40.4 | 21,853 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 39.36 per share. | 18 Feb 2021 | 200 | 66,106 | - | 39.4 | 7,871 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 41.82 per share. | 16 Feb 2021 | 2,750 | 68,926 | - | 41.8 | 115,014 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 41.17 per share. | 16 Feb 2021 | 1,300 | 66,506 | - | 41.2 | 53,520 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 38.56 per share. | 16 Feb 2021 | 600 | 68,026 | - | 38.6 | 23,138 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 42.67 per share. | 16 Feb 2021 | 300 | 68,626 | - | 42.7 | 12,802 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 39.86 per share. | 16 Feb 2021 | 220 | 67,806 | - | 39.9 | 8,769 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 41.68 per share. | 16 Feb 2021 | 200 | 66,306 | - | 41.7 | 8,336 | Common Stock |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 17,500 | 71,676 | - | 0 | Common Stock | |
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | 03 Aug 2020 | 6,500 | 0 | - | - | Series B Convertible Preferred Stock | ||
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | 03 Aug 2020 | 4,361 | 54,176 | - | - | Common Stock | ||
|
Kalaris Therapeutics Inc.
|
Brett R. Hagen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 43,400 | 43,400 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges